Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Daily Aspirin Risks May Outweigh Benefits

By HospiMedica International staff writers
Posted on 14 Jan 2014
Healthy adults who take aspirin daily to ward off potential heart disease may suffer more harm than good, according to a new review of studies.

Researchers at the University of Warwick (Coventry, United Kingdom) reviewed data sources that included ten electronic bibliographic databases, contact with experts, and scrutiny of the reference lists of included past studies, with eligible studies restricted to publications from 2008 to 2012. More...
They then used novel methods to reevaluate the balance of benefits and harms of using preventive aspirin. The researchers found that of 2,572 potentially relevant papers, just 27 met the inclusion criteria.

The results showed that regular aspirin intake resulted in the successful avoidance 60–84 major cardiovascular disease (CVD) events and 34–36 colorectal cancer deaths per 100,000 person-years. However, in the same time span, 46–49 major bleeds and 68–117 gastrointestinal bleeds in 10,000 people in a 10-year period also occurred. This translates to a 37% increased risk of stomach bleeding and a 38% increase in the risk of hemorrhagic stroke. The study was published on December 5, 2013, in PLoS One.

“We have found that the benefit from regular aspirin use in primary prevention of CVD is modest, while its use increases risk of hemorrhagic stroke and major and minor bleeding,” concluded lead author Paul Sutcliffe, MD, and colleagues of Warwick Medical School. “We need to be extremely careful about promoting the daily use without fully understanding all the evidence.”

“The risks are finely balanced and for now there is not the evidence to advise people to take it. It would be lovely to say over-50’s should take an aspirin a day and have much less cancer, but the research hasn't yet been done and we should be cautious,” added corresponding author Aileen Clarke, MD. “We need to be extremely careful about over-promoting aspirin.”

Aspirin has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels. Because the platelet patch can grow large enough to block blood flow—both locally and downstream—aspirin is also used long-term, at low doses, to help prevent heart attacks, strokes, and blood clot formation in people at high risk of thrombosis. Aspirin may be also be effective at preventing certain types of cancer, particularly colorectal cancer.

Related Links:

University of Warwick



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.